Agentic AI: Unlocking $450 Billion in Value for Life Sciences Marketing
A new wave of artificial intelligence, known as agentic AI, is poised to revolutionize how life sciences companies engage with healthcare professionals (HCPs), potentially unlocking up to $450 billion in economic value globally by 2028. This technology promises to overcome longstanding challenges with data silos and fragmented insights, enabling more personalized communication and demonstrably improved marketing ROI.
Life sciences organizations often possess a wealth of data about HCPs, yet struggle to leverage it effectively when critical moments arise. Consider a physician who recently attended a conference highlighting a competitor’s promising drug trial and subsequently shifted prescriptions. Traditionally, this information – residing in separate CRM, event databases, and claims data systems – would remain inaccessible to sales representatives before their next interaction. This disconnect hinders targeted engagement and limits the impact of sales efforts.
The Power of a Unified HCP View
Agentic AI offers a powerful solution by delivering a unified view of HCPs and extracting actionable insights from disparate data sources. By streamlining decision-making and execution, this technology empowers marketing teams – even those with limited resources – to operate with greater efficiency. According to a recent report, 69% of executives are planning to utilize AI agents in their marketing processes by the end of 2028.
One of the biggest hurdles for life sciences marketers is achieving a single, comprehensive view of the HCP. An omnichannel view, coordinating experiences across all channels, is increasingly vital, particularly as in-person meetings become less frequent – a trend accelerated by the COVID-19 pandemic. Representatives must maximize each interaction, beginning with intelligence specifically tailored to the individual HCP.
Breaking Down Data Silos with AI
Siloed data prevents a holistic understanding of the HCP, leaving sales representatives unprepared during valuable meetings. This fragmentation not only impedes the delivery of consistent, omnichannel experiences but also obscures a clear understanding of marketing ROI. Agentic AI doesn’t eliminate the challenge of HCP access, but it does unify siloed data, making it more accessible and actionable for both representatives and marketers.
Instead of relying on data engineers to build new pipelines, an AI agent can autonomously query existing systems. For example, it could be tasked with identifying “oncologists in the Northwest who have a 20% lower prescription volume but attended our last medical congress.” This capability extends to simplifying ROI calculations, providing a clearer picture of marketing effectiveness.
Agentic AI in Action: A Marketing Workflow Transformation
Imagine a sales representative equipped with an AI agent assisting with call and visit planning. This agent could answer questions such as: “What messages has my HCP responded to most recently?” “Do we have data on prescription patterns?” and “Can you create a detailed intelligence brief on my HCP?” The AI agent consolidates data, providing quick access to:
- Their most recent conversation with the HCP
- The HCP’s prescribing behavior
- Thought leaders the HCP follows
- Relevant content to share with the HCP
- The HCP’s preferred outreach channels (in-person visits, emails, webinars, etc.)
Furthermore, the AI can generate a custom call plan based on the unified HCP profile, enabling personalized value delivery that respects the provider’s time and communication preferences. Following each interaction, the agent can recommend follow-up steps to maintain a consistent experience.
Preparing for Implementation: From Prompts to Autonomous Execution
Agentic AI represents a shift from simply answering prompts to autonomously executing tasks. This requires a change in mindset for sales representatives, evolving from asking questions to coordinating specialized AI agents – one for planning, another for content retrieval, a third for scheduling and measurement, and a fourth for ensuring compliance. All of this operates under human oversight.
Successful implementation begins with AI-ready data – standardized, accessible, complete, and trustworthy. This enables:
- Faster decision making: Predictive analytics provide near real-time alerts, allowing proactive action.
- Personalization at scale: Customized experiences can be delivered to thousands of HCPs simultaneously with a small, AI-enabled team.
- True marketing ROI: Instead of relying on historical reports, marketers can finally determine which activities directly drive prescriptions.
Alignment between marketing and IT teams is crucial, establishing a shared understanding of tangible value and identifying key performance indicators (KPIs) such as increased HCP engagement or sales representative productivity. A learnings-based approach, coupled with tailored use cases for global organizations, will maximize ROI.
A New Operating Layer for Commercial Teams
Agentic AI isn’t merely another technology; it’s a new operating layer for commercial teams. However, its full potential is realized only with AI-ready data, trustworthy deployment, and workflow redesign. By making it easier for sales representatives to connect effectively with HCPs, providing them with necessary resources, and guiding follow-up steps, agentic AI can transform marketing organizations. Teams can unlock value from existing data through a strategy prioritizing data quality, platform efficacy, real-world use cases, and measurable outcomes, ultimately benefiting both the HCP – through directly relevant content – and the marketing team through increased engagement and conversion.
Briggs Davidson, Senior Director of Life Sciences at Capgemini Invent, advises C-suite leaders on leveraging data, analytics, and digital strategy to drive transformation and marketing impact. With over 20 years of experience, he leads initiatives across omnichannel orchestration, generative AI, and marketing science, delivering measurable results for global life sciences and healthcare clients. He is also a published thought leader on performance marketing and first-party data strategy.
